Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Go back to Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
(NASDAQ: LEXX) Delayed: 2.92 --0 (-0%)
Previous Close $2.92    52 Week High $ 
Open $2.92    52 Week Low $ 
Day High $2.92    P/E N/A 
Day Low $2.92    EPS $ 
Volume 1